In a proud milestone for Goa, Dr. Akash Anil Ringane has become the first Goan to clear the prestigious Fellowship of the European Board of Nuclear Medicine (EBNM), held in Barcelona, Spain, in 2025. This elite recognition marks a significant achievement not only for Dr. Ringane but also for the medical community of Goa and India at large.
Dr. Ringane’s journey began in Comba, where he completed his schooling at Mahila Nutan and Damodar Higher Secondary School. He later pursued his medical education at the esteemed Goa Medical College, which laid the foundation for his deep passion for nuclear medicine — a field that plays a critical role in modern diagnostics and cancer therapy.
The Fellowship of the European Board of Nuclear Medicine is among the most respected certifications in the field, assessing excellence in clinical knowledge, research, and practical application. Earning this title is a mark of international distinction and opens doors to global research and clinical collaborations.
Dr. Ringane’s accomplishment is being hailed across the state, with numerous messages of congratulations pouring in from the medical fraternity, academic institutions, and Goan citizens who view this as a shining example of Goan excellence reaching global heights.
Speaking on his achievement, those close to Dr. Ringane have shared that it was years of hard work, dedication, and an unwavering commitment to excellence that brought him to this point. His success is a beacon of inspiration for future generations of students and professionals in the state who aspire to make their mark on the global stage.
Dr. Ringane’s story is more than just a personal success; it’s a celebration of Goan talent, academic foundations, and global ambition — proving once again that excellence knows no boundaries.
Goa, April 17, 2025: Manipal Hospital Goa today marked a significant milestone in advanced cancer care with the launch of Selective Internal Radiation Therapy (SIRT), also known as Transarterial Radioembolization (TARE), for the treatment of liver tumors. The event titled “SIRT – A Game Changer in Liver Tumor” was organized by Dr. Charudutt J Sambhaji, Chief of Radiology & Consultant – Interventional Radiology, and Dr. Pankaj Mhatre, Consultant – Nuclear Medicine, Manipal Hospital Goa featured leading global and national experts in oncology and interventional radiology. It signals a new frontier in the hospital’s commitment to precision and personalized cancer care.
The highlight of the event was a keynote session on “New Frontiers in Selective Internal Radiation Therapy (SIRT)” by Prof. Dr. Pierce K. H. Chow, Professor and Program Director at Duke-NUS Medical School, Singapore, and Senior Consultant Surgeon at the National Cancer Centre, Singapore. The session was followed by an insightful discussion on “Optimizing SIRT Dosimetry and Outcome,” led by Dr. Sanjay S. Baijal, Chairman, Interventional and Diagnostic Radiology at Medanta the Medicity, Gurugram.
On this occasion, Dr Charudatt has stated, “The launch of SIRT at Manipal Hospital Goa represents a quantum leap in cancer care in the region. It brings the latest international advancements in interventional oncology to our doorstep, offering new hope to patients battling complex liver cancers.”
As cancer cases are on the rise, SIRT is emerging as a key treatment for liver cancers. SIRT is a targeted treatment for liver cancers like hepatocellular carcinoma (HCC) and metastatic liver tumors. It involves delivering radioactive microspheres directly into the blood vessels that supply the tumor, allowing for precise radiation with minimal damage to surrounding healthy tissue. It is a detailed pre-procedure preparation, including lab tests, image studies, and a preliminary angiogram with a Tc-99m MAA scan to assess particle shunting. Patients are then admitted for the main procedure, which involves injecting tiny radioactive beads into the liver through its blood vessels. A short hospital stay of 1–2 days is usually needed.
Dr. Salkar has stated, “SIRT is not just a procedure; it’s a collaborative approach involving interventional radiologists, nuclear medicine specialists, surgical oncologists, hepatologists, and medical oncologists. Our goal is to ensure a seamless experience and improved outcomes for patients through coordinated care and cutting-edge therapy.”
The event witnessed the participation of a distinguished panel of experts from across specialties and hospitals, reflecting the collaborative nature of advanced liver cancer care. From Manipal Hospital, Dr. Shekhar Salkar, Senior Consultant – Surgical Oncology, Dr. Jacob George, Consultant – Medical Oncologist, Dr. Rohan Badave, Consultant – Gastroenterology & Hepatologist, Dr. Sredharan M, Consultant – Surgical Oncologist, Dr. Vaibhav Shakya, Consultant – Radiation Oncology, and Dr. Sujoy Fernandes, Consultant – Radiation Oncology, attened the event. Besides the doctors from Manipal Hospital, Dr. Harish Peshwe, Consultant – Gastroenterologist, Dr. Sanjay Altekar, Consultant – Gastroenterologist, Dr. Jean Louis Menezes, Consultant- Surgical Oncologist, Dr. Anupama Borkar, Consultant – Medical Oncologist, also attended the event.
The event served as an important platform for knowledge sharing and clinical collaboration. It has also executed SIRT’s role as a precision therapy that is helping to reshape the treatment paradigm for liver cancer.
